Zobrazeno 1 - 10
of 200
pro vyhledávání: '"C Arnoulet"'
Autor:
Jerome Rey, R. Bouabdallah, Jean-Marc Schiano, A M Stoppa, D. Coso, C. Arnoulet, Jean-Louis Gastaut, Vadim Ivanov, T. Aurran-Schleinitz
Publikováno v:
La Revue de Médecine Interne. 29:424-435
Resume Introduction La leucemie lymphoide chronique (LLC) represente la leucemie la plus frequente dans le monde occidental. Sa prise en charge a ete profondement transformee ces dix dernieres annees par les avancees dans la comprehension de la physi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b84e612c5e6c12b6b907e10ed607f61
https://doi.org/10.1016/j.revmed.2007.10.414
https://doi.org/10.1016/j.revmed.2007.10.414
Autor:
R. Bouabdallah, Patrick Ladaique, Didier Blaise, Karin Bilger, Mohamad Mohty, Norbert Vey, Christian Chabannon, D. Sainty, J. Camerlo, C. Arnoulet, Vadim Ivanov, D. Maraninchi, Catherine Faucher, V.J. Bardou
Publikováno v:
Transfusion. 44:501-508
BACKGROUND: RBCT (RBCT) requirements of stem cell transplant (SCT) recipients are often substantial and may be related to transplant type. STUDY DESIGN AND METHODS: An analysis was done of RBCT requirements and Hb recovery kinetic in the first 60 day
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d50b54cc36969d0994b70d9f59a4a5a
https://doi.org/10.1111/j.1537-2995.2004.03317.x
https://doi.org/10.1111/j.1537-2995.2004.03317.x
Autor:
Valérie-Jeanne Bardou, Dominique Maraninchi, G Gravis, J. Jacquemier, Dominique Genre, Christian Chabannon, Danielle Sainty, Patrice Viens, C Arnoulet, Patrick Ladaique, François Bertucci, Anthony Gonçalves, G Houvenaeghel, F Viret, A C Braud
Publikováno v:
Bone Marrow Transplantation. 32:1059-1064
The purpose of this study was to evaluate the presence of micrometastatic cells in the apheresis products from patients with breast cancer, and also to determine if repeated infusion of contaminated products had any clinical impact. A total of 94 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58c810eab5b9573fd4306d18577d7c6e
https://doi.org/10.1038/sj.bmt.1704283
https://doi.org/10.1038/sj.bmt.1704283
Autor:
Alessandro Moretta, Françoise Mallet, Danielle Sainty, C Arnoulet, Jean-Albert Gastaut, Daniel Olive, Simona Sivori, Régis Costello, Reviron D
Publikováno v:
Leukemia. 16:855-860
We describe a patient with acute myeloid leukemia (AML) who developed polyclonal large granular lymphocyte (LGL) proliferation. The reciprocal evolution of AML and LGLs suggested that these LGLs had an anti-tumor activity. The patient's LGLs killed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b24c890f006f74af7a165b0a01ec27
https://doi.org/10.1038/sj.leu.2402488
https://doi.org/10.1038/sj.leu.2402488
Autor:
R. Naumann, R. Nowak, D. Sainty, I. Besson, C. Arnoulet, G. Ehninger, Y. Bux, U. Oelschlaegel
Publikováno v:
Clinical & Laboratory Haematology. 23:81-90
PNH is a disorder of the pluripotent stem cells resulting in a deficient expression of membrane-bound GPI-anchored proteins in different cell types. Several flow cytometric approaches are designed to detect this antigen deficiency. But they all requi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ddf3367564303fc342dca752ac7e8dc7
https://doi.org/10.1046/j.1365-2257.2001.00357.x
https://doi.org/10.1046/j.1365-2257.2001.00357.x
Autor:
Danielle Sainty, C Arnoulet, Régis Costello, Jean-Albert Gastaut, Françoise Mallet, Hervé Chambost, Daniel Olive
Publikováno v:
Leukemia. 13:1513-1518
Minimally differentiated acute myeloid leukemia (AML-M0) is a rare FAB subtype (2-3% of AMLs) of poor prognosis. The aim of our study was to characterize AML-M0 expression and regulation of adhesion/costimulatory molecule involved in immune recogniti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72f87f21e1aee75a54fbc71d11973b61
https://doi.org/10.1038/sj.leu.2401519
https://doi.org/10.1038/sj.leu.2401519
Autor:
P. Validire, D. Sainty, L. Edelman, C. Arnoulet, E. Monchâtre, J.-C. Durand, J.P. Lotz, C Bayle
Publikováno v:
Hematology and Cell Therapy. 41:66-70
Through two clinical studies, tumor cells were searched for in the bone biopsies and cytapherisis of patients suffering from inflammatory tumors and who had undergone intensive therapy and autografts (Pegase 2 program). In these studies we used immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::205934dbd4ef839468cf65d95ec7305f
https://doi.org/10.1007/s00282-999-0066-y
https://doi.org/10.1007/s00282-999-0066-y
Publikováno v:
Hematology and Cell Therapy. 39:261-264
Immune clinical events and pattern of recovery of total lymphocytes, T cells and CD4+/CD8+ T cell subsets, B cells and NK cells, were analysed after allogeneic blood cell transplantation (BCT) for 12 months following transplant (n = 33). Results were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3265f1e0e90a4dd468c59f4005ce5638
https://doi.org/10.1007/s00282-997-0261-7
https://doi.org/10.1007/s00282-997-0261-7
Autor:
C Arnoulet, Jean Imbert, Patrick Lécine, M J Mozziconacci, Jean Gabert, D Maraninchi, Jean-Albert Gastaut, Danielle Sainty, Marina Lafage-Pochitaloff, Régis Costello, A Cusenier
Publikováno v:
Leukemia. 11:644-650
Pericentric inversion of chromosome 16, translocation (16;16) and del(16q), resulting in a chimerical fusion of CBFbeta and MYH11 genes, are typically seen in the M4Eo French-American-British (FAB) classification subset of acute myelogenous leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beac1e3bafda9581258fa2287514768c
https://doi.org/10.1038/sj.leu.2400629
https://doi.org/10.1038/sj.leu.2400629
Autor:
T, Aurran-Schleinitz, C, Arnoulet, V, Ivanov, D, Coso, J, Rey, J-M, Schiano, A-M, Stoppa, R, Bouabdallah, J-A, Gastaut
Publikováno v:
La Revue de medecine interne. 29(5)
Chronic lymphocytic leukemia (CLL) is the most common leukaemia in the Western world. Recent advancement in the aetiology, pathophysiology and the development of new therapeutics tools have significantly modified the current management of CLL.The cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::934666d03b8c752e6536b91cebff7da6
https://pubmed.ncbi.nlm.nih.gov/18359538
https://pubmed.ncbi.nlm.nih.gov/18359538